nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in the development of biomarkers for epilepsy
|
Pitkänen, Asla |
|
2016 |
15 |
8 |
p. 843-856 14 p. |
artikel |
2 |
Asla Pitkänen: hope on the horizon for epilepsy prevention
|
Morgan, Jules |
|
2016 |
15 |
8 |
p. 795- 1 p. |
artikel |
3 |
Charlotte Cordonnier
|
|
|
2016 |
15 |
8 |
p. 796- 1 p. |
artikel |
4 |
Corrections
|
|
|
2016 |
15 |
8 |
p. 787- 1 p. |
artikel |
5 |
Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study
|
Fotiadis, Panagiotis |
|
2016 |
15 |
8 |
p. 811-819 9 p. |
artikel |
6 |
Dementia after stroke due to intracerebral haemorrhage
|
Salman, Rustam Al-Shahi |
|
2016 |
15 |
8 |
p. 779-780 2 p. |
artikel |
7 |
Dementia in Down's syndrome: still much to learn
|
The Lancet Neurology, |
|
2016 |
15 |
8 |
p. 775- 1 p. |
artikel |
8 |
Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study
|
Moulin, Solène |
|
2016 |
15 |
8 |
p. 820-829 10 p. |
artikel |
9 |
Duchenne muscular dystrophy: meeting the therapeutic challenge
|
Flanigan, Kevin M |
|
2016 |
15 |
8 |
p. 785-787 3 p. |
artikel |
10 |
Eames design: from fractured limbs to human cognition
|
Martin, Colin |
|
2016 |
15 |
8 |
p. 799- 1 p. |
artikel |
11 |
Early onset Alzheimer's disease: many mountains to climb
|
Morgan, Jules |
|
2016 |
15 |
8 |
p. 798- 1 p. |
artikel |
12 |
Functional (psychogenic) saccadic oscillations and oculogyric crises
|
Baizabal-Carvallo, José Fidel |
|
2016 |
15 |
8 |
p. 791- 1 p. |
artikel |
13 |
Functional (psychogenic) saccadic oscillations and oculogyric crises – Authors' reply
|
Kaski, Diego |
|
2016 |
15 |
8 |
p. 791-792 2 p. |
artikel |
14 |
Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond
|
Cuyvers, Elise |
|
2016 |
15 |
8 |
p. 857-868 12 p. |
artikel |
15 |
Neural correlates of consciousness in patients who have emerged from a minimally conscious state: a cross-sectional multimodal imaging study
|
Di Perri, Carol |
|
2016 |
15 |
8 |
p. 830-842 13 p. |
artikel |
16 |
Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation
|
Chamorro, Ángel |
|
2016 |
15 |
8 |
p. 869-881 13 p. |
artikel |
17 |
News in brief
|
|
|
2016 |
15 |
8 |
p. 800- 1 p. |
artikel |
18 |
Phantom limb and Lhermitte
|
Drouin, Emmanuel |
|
2016 |
15 |
8 |
p. 796- 1 p. |
artikel |
19 |
Pharmacotherapy in Down's syndrome: which way forward?
|
Fernandez, Fabian |
|
2016 |
15 |
8 |
p. 776-777 2 p. |
artikel |
20 |
Rabies: the most common cause of fatal encephalitis in India
|
Bagcchi, Sanjeet |
|
2016 |
15 |
8 |
p. 793-794 2 p. |
artikel |
21 |
Riluzole in patients with hereditary cerebellar ataxia
|
Brandsma, Rick |
|
2016 |
15 |
8 |
p. 788- 1 p. |
artikel |
22 |
Riluzole in patients with hereditary cerebellar ataxia
|
Saute, Jonas Alex Morales |
|
2016 |
15 |
8 |
p. 788-789 2 p. |
artikel |
23 |
Riluzole in patients with hereditary cerebellar ataxia – Authors' reply
|
Romano, Silvia |
|
2016 |
15 |
8 |
p. 789- 1 p. |
artikel |
24 |
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
|
de la Torre, Rafael |
|
2016 |
15 |
8 |
p. 801-810 10 p. |
artikel |
25 |
Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy
|
Straub, Volker |
|
2016 |
15 |
8 |
p. 882-890 9 p. |
artikel |
26 |
Standardisation of research strategies in acute ischaemic stroke
|
Fraser, Justin F |
|
2016 |
15 |
8 |
p. 784-785 2 p. |
artikel |
27 |
The cerebral cortex in cerebral amyloid angiopathy
|
Schneider, Julie A |
|
2016 |
15 |
8 |
p. 778-779 2 p. |
artikel |
28 |
The help of biomarkers in the prevention of epilepsy
|
Koepp, Matthias J |
|
2016 |
15 |
8 |
p. 782-784 3 p. |
artikel |
29 |
The see-saw brain: recovering consciousness after brain injury
|
Chennu, Srivas |
|
2016 |
15 |
8 |
p. 781-782 2 p. |
artikel |
30 |
Understanding the brain: breakthroughs, blunders, and brilliance
|
Morgan, Jules |
|
2016 |
15 |
8 |
p. 797- 1 p. |
artikel |
31 |
Why use sex hormones in relapsing-remitting multiple sclerosis?
|
Lechtenberg, Richard |
|
2016 |
15 |
8 |
p. 789-790 2 p. |
artikel |
32 |
Why use sex hormones in relapsing-remitting multiple sclerosis? – Authors' reply
|
Voskuhl, Rhonda |
|
2016 |
15 |
8 |
p. 790-791 2 p. |
artikel |